Latest updates for Amrx
Fresh curated links around AMRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Amneal: A Robust Drug Portfolio Worth Watching, Driving Further Upside Potential
- Amylyx (AMLX) Q1 2026 Earnings Transcript
- Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Amylyx (AMLX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Justin KleeCo-Chief Executive Officer — Joshua CohenChief Commer...
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
12 Health Care Stocks Moving In Friday's After-Market Session
Importance Rank: 1 read more
Immuneering Corporation: Updates Inbound At The End Of The Month
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial...
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
Accelerant (ARX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...
Accelerant (ARX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 14, 2026 at 8 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Jeffrey RadkeChief Financial Officer — Linda HuberHea...
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026. Importance Rank: ...
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
EXXUA -- with only a partial quarter of full sales force support -- contributed $2.4 million in net revenue supported by rapid monthly compounding script growth ratesTotal net reve...
AmeraMex International Wraps Up $900,000 in Heavy Equipment Orders
Chico, California–(Newsfile Corp. – May 5, 2026) – AmeraMex International, Inc . (OTCID: AMMX),…
Revolution Medicines
Revolution Medicines Anonymous (not verified) Tue, 05/05/2026 - 02:20 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...
Lumexa (LMRI) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateTuesday, May 12, 2026 at 5 p.m. ET Call participantsChief Executive Officer — Caitlin ZullaChief Financial Officer — J. Anthony MartinTakeawaysC...
AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
MeiraGTx Holdings plc (MGTX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
Veradigm Inc. (MDRX) Discusses Progress on SEC Filings, Relisting Efforts and Strategic Update Transcript
Acurx (ACXP) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...
Acurx (ACXP) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026 at 8 a.m. ETCALL PARTICIPANTSPresident & Chief Executive Officer — David P. LuciChief Financial Officer — Robert J. Sh...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.